Transaction · 0000950170-25-032758

Rothfuss Cristin

Rothfuss Cristin, EVP, GC, reported a transaction classified as withholding at Sarepta Therapeutics, Inc. involving 391.000000 shares for an estimated $40574.07. Reported holdings after the transaction were 13621.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FEVP, GC
SRPTSarepta Therapeutics, Inc.
Filing timeMar 05
Trade dateMar 03, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

SRPT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
SRPT since 2025-03-05Filed 553 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0000950170-25-032758
Common Stock
Transaction date
Mar 03, 2025
Filed Mar 05, 2025, 01:00 AM · 2d delay
Shares
391 sh
$10.3k per share
Estimated value
-$4.05M
Computed from shares × price
Holdings after
13.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.

  2. F2

    Amount of Securities Beneficially Owned includes 195 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.

Original filing · 0000950170-25-032758
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

SRPT